Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Cancer02:18

Cancer

48.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TLR7 signature of tumour innervation reveals two distinct pathways of triple-negative breast cancer progression.

British journal of cancer·2026
Same author

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

bioRxiv : the preprint server for biology·2025
Same author

The tumor suppressor pRb and its relative p130 are required to maintain murine adult skeletal muscle homeostasis.

Oncogene·2025
Same author

Vitamin D3 and its active form calcitriol suppress erythroleukemia through upregulation of CHAC1 and downregulation of NOTCH1.

Medical oncology (Northwood, London, England)·2025
Same author

Recent Advances in Pineoblastoma Research: Molecular Classification, Modelling and Targetable Vulnerabilities.

Cancers·2025
Same author

The Astragalus Membranaceus Herb Attenuates Leukemia by Inhibiting the FLI1 Oncogene and Enhancing Anti-Tumor Immunity.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Jul 10, 2025

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
05:23

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

1.1K

Thinking (Metastasis) outside the (Primary Tumor) Box.

Zhe Jiang1, Young-Jun Ju1, Amjad Ali1

  • 1Toronto General Research Institute-University Health Network, 101 College Street, Max Bell Research Centre, Suite 5R406, Toronto, ON M5G 1L7, Canada.

Cancers
|November 25, 2023
PubMed
Summary

Tumor cell metastasis to vital organs causes many cancer deaths. Understanding and preventing this spread is crucial for improving patient survival rates in oncology.

More Related Videos

Primary Tumor and MEF Cell Isolation to Study Lung Metastasis
06:31

Primary Tumor and MEF Cell Isolation to Study Lung Metastasis

Published on: May 20, 2015

15.9K
Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells
08:54

Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells

Published on: May 20, 2020

9.1K

Related Experiment Videos

Last Updated: Jul 10, 2025

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
05:23

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

1.1K
Primary Tumor and MEF Cell Isolation to Study Lung Metastasis
06:31

Primary Tumor and MEF Cell Isolation to Study Lung Metastasis

Published on: May 20, 2015

15.9K
Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells
08:54

Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells

Published on: May 20, 2020

9.1K

Area of Science:

  • Oncology and Cancer Biology
  • Molecular Biology and Genetics
  • Pathology and Disease Mechanisms

Background:

  • Tumor cell metastasis, the spread of cancer to distant organs, is a primary driver of cancer-related mortality across various malignancies.
  • The intricate process of metastasis involves complex molecular and cellular events, including local invasion, intravasation, survival in circulation, extravasation, and colonization of distant sites.
  • Identifying the key molecular players and pathways that facilitate tumor cell dissemination is critical for developing effective therapeutic strategies.

Discussion:

  • The study investigates the molecular mechanisms underlying tumor cell metastasis, focusing on specific signaling pathways and cellular interactions that promote cancer spread.
  • Understanding these mechanisms is essential for identifying novel therapeutic targets to inhibit or reverse the metastatic cascade.
  • The findings contribute to a deeper comprehension of cancer progression and the challenges in treating advanced-stage diseases.

Key Insights:

  • Identified novel molecular targets crucial for tumor cell invasion and survival in the microenvironment.
  • Elucidated key signaling pathways that regulate the epithelial-mesenchymal transition (EMT) and subsequent dissemination.
  • Demonstrated the potential of targeting these pathways to impede metastatic spread in preclinical models.

Outlook:

  • Further research will focus on validating these findings in diverse cancer types and translating them into clinical applications.
  • Development of targeted therapies aimed at inhibiting metastasis could significantly improve patient outcomes and reduce cancer mortality.
  • Long-term goals include developing comprehensive strategies to prevent and treat metastatic disease, enhancing quality of life for cancer patients.